Results 241 to 250 of about 93,221 (259)

Temozolomide

Reactions Weekly, 2007
openaire   +1 more source

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

Lancet, The, 2017
Michael A Vogelbaum, Anna K Nowak, Alba Ariela Brandes   +2 more
exaly  

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

New England Journal of Medicine, 2017
James R Perry, Normand J Laperriere, Christopher J O'callaghan   +2 more
exaly  

Anaplastic glioma: benefit of temozolomide clarified

Nature Reviews Clinical Oncology, 2021
exaly  

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

New England Journal of Medicine, 2005
Roger Stupp, Michael Weller, Alba Ariela Brandes   +2 more
exaly  

Temozolomide

Reactions Weekly, 2006
openaire   +2 more sources

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Lancet Oncology, The, 2009
Roger Stupp, Monika E Hegi, Peter Hau
exaly  

Temozolomide

Reactions Weekly, 2009
openaire   +1 more source

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

Lancet Oncology, The, 2012
Wolfgang Wick, Michael Platten, Ghazaleh Tabatabai   +2 more
exaly  

Temozolomide resistance in glioblastoma multiforme

Genes and Diseases, 2016
Sang Y Lee
exaly